MedInnovate Limited is registered in England & Wales No. 05318138 © MedInnovate 2011
Creating, developing and transforming life science businesses
Nicholas Edwards
Dr Nicholas Edwards (Chairman) graduated in Physiological Sciences from The Queen’s College, Oxford in 1982 and then completed his training in Clinical Medicine (BM, BCh) at Green College (now Green Templeton College), Oxford in 1985. After research into the use of Artificial Intelligence to perform medical diagnosis, he completed house jobs in Cardiology and General Surgery before joining Andersen Consulting in 1986. He spent 18 years with Andersen Consulting (now known as Accenture), including 8 years as a partner, and was the global leader of Accenture’s Pharmaceutical R&D business. Typical projects with global pharmaceutical companies included :|
○
|
Helping to build a global, world class drug development function from businesses based in Germany, France and the United States. This involved analyses of organisational and process models and a change management strategy to achieve a successful transition.
|
|
○
|
Developing a drug research strategy for a major pharmaceutical company with centres on multiple sites to ensure that they worked together to common standards and a unified vision.
|
|
○
|
Supporting the Head of Development develop an integrated organisation after the merger of two large pharmaceutical companies.
|
|
○
|
Developing a strategy to achieve dominance in the oncology marketplace for a company with several existing oncology products.
|
In 2005, he was one of the founders of Kinapse, a business focussed on providing consulting and outsourcing services to the pharmaceutical industry. He has remained Chairman of this business since its foundation as it has grown into a multi-million pound business employing over 100 people. He has also completed consulting projects for Kinapse such as :
|
○
|
Supporting the UK Department of Health in understanding the attractiveness of the UK as a centre for commercial clinical research.
|
|
○
|
Helping the CEO and CFO of a Contract Research Organisation identify strengths and weaknesses of their organisation and develop a strategy for growth.
|
He has been an investor and supporter of several life science start up businesses. This has included providing advice and support to the leadership of each businesses. He is the Chairman of Oxtex, a spin out from the University of Oxford that is developing a novel surgical implant device.
Nicholas is part of the Kilfinan Group - a network of senior business people who provide free and informal mentoring to charity chief executives.
Nicholas is an Associate Fellow of Green Templeton College, Oxford and sits on its Development Committee. He is currently working on a Centre based within the University of Oxford developing better methods of translating medical innovations into useable treatments, with an initial focus on pharmaceutical R&D.